Concepedia

Laura Hargrove

LH

Statistics

Publications

24

Citations

943

H-Index

18

Active since

2013

Affiliations

Central Texas Veterans Health Care System(Current)

Baylor Scott & White Health

Texas A&M Health Science Center

Texas A&M University

Indiana University School of Medicine

Laura Hargrove is an author at Central Texas Veterans Health Care System specializing in liver disease, medicine, and hepatic pathophysiology.

ORCID

Publications per year

2013–2021

24

Publications

24

Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling

Vik Meadows, Lindsey Kennedy, Burcin Ekser et al. · Hepatology · 2021 · 82 citations · Full text

, , +17

Inhibition of mast cell‐secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2−/− mice

Hannah Jones, Laura Hargrove, Lindsey Kennedy et al. · Hepatology · 2016 · 81 citations · Full text

, , +17

Inhibition of Mast Cell-Derived Histamine Decreases Human Cholangiocarcinoma Growth and Differentiation via c-Kit/Stem Cell Factor–Dependent Signaling

Christopher M. Johnson, Victoria Huynh, Laura Hargrove et al. · American Journal Of Pathology · 2015 · 71 citations · Full text

, , +11

Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2–/– mice and human cholangiocarcinoma tumorigenesis: [RETRACTED]

Lindsey Kennedy, Laura Hargrove, Jennifer Demieville et al. · Hepatology · 2018 · 71 citations · Full text

, , +15

Bile duct ligation–induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell–deficient KitW‐sh mice

Laura Hargrove, Lindsey Kennedy, Jennifer Demieville et al. · Hepatology · 2017 · 67 citations · Full text

, , +17

1–5 of 24